Ownership

Andrew Combs - Insider Trading & Ownership

Entity: Individual
Location: C/O Prelude Therapeutics Incorporated, 200 Powder Mill Road, Wilmington, DE
Summary: The estimated net worth of Andrew Combs is at least $332K dollars as of March 27, 2025. Andrew Combs is the Chief Chemistry Officer of Prelude Therapeutics Inc and owns shares of Prelude Therapeutics Inc (PRLD) stock worth about $332K.
All Insider Reports: All Insider Reports

Ownership of Andrew Combs

Symbol	Company	Relationship	Holdings Value	Past Year Net Change	Change %	Report Period
PRLD	Prelude Therapeutics Inc	Chief Chemistry Officer	$332K	+$155K	+87.1%	Mar 25, 2025

Insider Transactions Reported by Andrew Combs:

Sym	Company	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.